Arkolith/Insider Trading/THRX/Form 4

Foresite Capital Opportunity Management V, LLC

10% OwnerTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Jul 19, 2023
Net Buying
Open-Market Buys
$2.1M
Open-Market Sells
$0
Net Open-Market Flow
$2.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2023Buy(P)177K$2.97$524K1.4M
Jul 17, 2023Buy(P)523K$2.97$1.6M4.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-042720) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML